This site provides H1N1-related information and guidance for healthcare providers and facilities.

Changes to the 2009 H1N1 Vaccine and Supply Distribution Effective April 1, 2010
(Source: Centers for Disease Control and Prevention)

Vaccine Recalls and Expiration Updates

Other H1N1-related Alerts

Algorithm to Assist Clinicians with H1N1 Testing, Treating and Reporting

Vaccine Adverse Event Reporting System (VAERS) Healthcare Provider Letter and Reporting Form

Healthcare Providers and Facilities - Decision Tree for 2009 H1N1 Vaccination
(Source: Centers for Disease Control and Prevention)
To provide a decision tool for providers and healthcare facilities.

Frequently Asked Questions

_______________________________________________Back to top

Clinicians

• Questions & Answers - Morbid Obesity as a Risk Factor for Hospitalization and Death due to 2009 H1N1
  (Source: Centers for Disease Control and Prevention)
  
  
• Updated H1N1 Testing, Antiviral Treatment and Surveillance Guidance for Clinicians for the Current Low Influenza Levels in Florida
  (Source: Source: Florida Department of Health, Epidemiology)
  
  
• H1N1 Flu: Preparedness Tools for Healthcare Professionals
  (Source: Centers for Disease Control and Prevention)
  
  
• OSHA H1N1 Healthcare Inspections Procedures
  (Source: Occupational Safety and Health Administration)
  • Occupational Safety and Health Administration (OSHA) has released enforcement procedures to ensure uniform procedures when conducting inspections to minimize H1N1 exposure risk of staff.
    
    
• Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers Regarding Respiratory Protection For Preventing 2009 H1N1 Influenza Among Healthcare Personnel
  (Source: Centers for Disease Control and Prevention)
  
  
• Clinical Management of Human Infection with Pandemic (H1N1) 2009 - Updated Guidance Nov. 2009
  (Source: World Health Organization)
  
  

• Letter from the Commissioner to Nation's Healthcare Professionals on H1N1 Vaccine
  (Source: Food and Drug Administration)

  • A thank you letter from the Commissioner of Food and Drugs to all healthcare professionals for their extraordinary efforts during the 2009 H1N1 influenza outbreak.
    
    
• Letter to Providers Promoting PPSV for Adults
  (Source: Centers For Disease Control and Prevention)
  
  

• AHCA H1N1 Information Sheet
  (Source: Florida Agency for Healthcare Administration)

  • Includes explanation of H1N1-related declarations and waivers
    
    

• Guidelines for Health Care Systems - Procedure for Ordering PPE in Health Care Setting
  
  

• State/Jurisdiction Contact Information for Providers Interested in Providing H1N1 Vaccine
  (Source: Centers for Disease Control and Prevention)
  
  
• Advisory Committee on Immunization Practices (ACIP)
  • Recommendations and Guidelines: ACIP Presentation Slides: Special July 2009 Meeting
    
    
• For Providers: Prevention of Pneumococcal Infections Secondary to Seasonal and 2009 H1N1 Influenza Viruses Infection
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers: 2009 H1N1 and Pneumococcal Disease in the News
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers: Prevention of Pneumococcal Infections Secondary to Seasonal and 2009 H1N1 Influenza
  (Source: Centers for Disease Control and Prevention)
  
  

• Guidance for Testing, Treatment & Prophylaxis in Florida
  (Source: Florida Department of Health, Epidemiology)
  
  

• H1N1 Clinicians Questions and Answers
  (Source: Centers for Disease Control and Prevention)
  
  
• Identifying and Caring For Patients
  (Source: Centers for Disease Control and Prevention)
  
  
• Emergency Use Authorization (EUA): Medical Products
  (Source: Centers for Disease Control and Prevention)
  • Peramivir Information
    (Source: Food and Drug Administration)
    
    
• Clinical Data Collection Forms and Templates
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Guidance for the Detection of Influenza A Virus Using Rapid Influenza Diagnostic Tests
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Biosafety Guidance for All Individuals handling Clinical Specimens or Isolates containing 2009-H1N1 Influenza A Virus including Vaccine Strains
  (Source: Centers for Disease Control and Prevention)
   

Pharmacists

• 2009 H1N1 Influenza: Resources for Pharmacists
  (Source: Centers for Disease Control and Prevention)
  
  
• FDA Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions
  (Source: Food and Drug Administration)
  
  
• Flu Information for Pharmacists
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Pediatrics

• Pandemic Influenza Pediatric Office Plan Template
  (Source: Centers for Disease Control and Prevention)
  This template is a planning tool created by a team of pediatric experts intended to assist pediatric medical offices that may experience an increase in patient visits or workload due to pandemic influenza. It is designed so that planning teams can customize the plan based on the particular needs of their offices.
  
  
• Questions and Answers: Opening and Mixing Tamiflu Capsules with Liquids if Child Cannot Swallow Capsules
  (Source: Centers for Disease Control and Prevention)
  
  
• 2009-2010 Influenza Season Triage Algorithm for Children (18 years or Younger) With Influenza-Like Illness (PDF)
  (Source: Centers for Disease Control and Prevention)
  
  
• Pediatric Supplement: Recommendations for use of antiviral medications for 2009 H1N1 influenza in children and adolescents
  (Source: Centers for Disease Control and Prevention)
  

• Planning Guide for Vaccinating Pediatric Patients Against 2009 H1N1 Influenza in Primary Healthcare Settings
  (Source: Centers for Disease Control and Prevention)
  
  

• Updated Pediatric Antiviral Dosing Syringe and Compounding Information
  (Source: Centers for Disease Control and Prevention)
  
  

• Guidance on Prevention and Treatment of H1N1 Influenza Virus Infection in Infants and Children
  (Source: Centers for Disease Control and Prevention)
  
  
• Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection
  (Source: Centers for Disease Control and Prevention)
  
  
• Pediatrician Clinics Caring for Children
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Pregnant Women

• Recommendations for Obstetric Health Care Providers
  (Source: Centers for Disease Control and Prevention)
  
  
• Resources for Pregnant Women
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers for Pregnant Women: Use of Antivirals to Treat and Prevent Flu
  (Source: Centers for Disease Control and Prevention)
  
  
• Considerations Regarding 2009 H1N1 Influenza in Intrapartum and Postpartum Hospital Settings
  (Source: Centers for Disease Control and Prevention)
  
  
• H1N1 Flu: Resources for Obstetric Health Care Providers
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Vaccine

• Influenza Vaccine Update: from the Clinician Outreach and Communication Activity Conference Call, March 23, 2010
  (Source: Centers for Disease Control and Prevention)
  
  
• H1N1 Vaccine Waste Form
  (Source: Florida Department of Health, Florida SHOTS)
  
  
• Guidance for the Use of CSL 2009 H1N1 Monovalent Vaccine
  (Source: Centers for Disease Control and Prevention)
  
  
• Briefing: Safety of Pandemic Vaccines
  (Source: World Health Organization)
  
  

• 2009 H1N1 Influenza Vaccine Dose Spacing and Administration with Seasonal Influenza and Other Vaccines 
  (Source: Centers for Disease Control and Prevention)

  • This table for healthcare providers and planners provides information related to spacing between the two doses of 2009 H1N1 vaccine for children 6 months through 9 years of age and for administration of 2009 H1N1 vaccine with seasonal influenza and other vaccines.
    
    

• 2009 H1N1 Influenza Vaccine - Dose Spacing for Children 6 Months through 9 Years of Age
  (Source: Centers for Disease Control and Prevention)

  • This table for healthcare providers and planners provides information related to spacing between the two doses of 2009 H1N1 Vaccine for children 6 months through 9 years of age.
    
    
• Vaccine Supply Letter: CDC Director to State and Local Health Officials
  (Source: Centers for Disease Control and Prevention)
  
  

• 2009 H1N1 Vaccine Clinical Trial Results: Updates from NIAID(Source: National Institute of Allergy and Infectious Diseases)

  • The government-sponsored test trials for healthy adults, children, people more than 65 years of age, pregnant women, people with asthma, and people infected with HIV.
    
    

• Frequently asked questions on use of influenza A(H1N1) 2009 monovalent vaccines (2009 H1N1 monovalent influenza vaccines): Practical considerations for immunization programs and providers
  (Source: Centers for Disease Control and Prevention)
  
  

• Vaccine Safety

  • Vaccine Safety
    (Source: Centers for Disease Control and Prevention)
  • Federal Plans to Monitor Immunization Safety for the Pandemic 2009 H1N1 Influenza Vaccination Program
    (Source: Flu.gov)
  • H1N1 Vaccine Safety Monitoring
    (Source: Flu.gov)
    
    
• Q & A Regarding 2009 H1N1 Influenza Vaccine Supply
  (Source: Centers for Disease Control and Prevention)
  
  
• 2009 H1N1 Vaccine Dosage, Administration, and Storage
  (Source: Centers for Disease Control and Prevention)
  
  

• H1N1 Influenza A (H1N1) 2009 Monovalent Vaccine Dosage Chart
  (Source: Centers for Disease Control and Prevention)
  
  

• Interim guidance for use of 23-valent pneumococcal  polysaccharide vaccine during H1N1 outbreak
  (Source: Centers for Disease Control and Prevention)
  
  
• Key Facts About 2009 H1N1 Flu Vaccine
  (Source: Centers for Disease Control and Prevention)
  
  
• Vaccine Information Sheets (VIS)
  (Source: Centers for Disease Control and Prevention)
  • Explains to vaccine recipients, their parents, or their legal representatives both the benefits and risks of the vaccine.
    

• Questions & Answers: 2009 H1N1 Nasal Spray Vaccine
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions & Answers for People at High Risk of Developing Flu-Related Complications
  (Source: Centers for Disease Control and Prevention)
  
  

• FACT SHEET - Influenza A (H1N1) 2009 Monovalent Vaccines
  (Source: Florida Department of Health)
  
  

• CDC's Vaccine Storage and Handling Toolkit
  (Source: Centers for Disease Control and Prevention)
  
  

• Product Insert Sheets for FDA-approved H1N1 Swine Flu Vaccines
  (Source: Food and Drug Administration)
  
  

• Pediatric H1N1 Vaccine Clinical Trail Data
  (Source: National Institutes of Health)

  • Early Results: In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine

  • NIAID to Begin Trials of Candidate H1N1 Vaccines in Children

  • Questions and Answers - Pediatric Trials of 2009 H1N1 Influenza Vaccine at NIAID Vaccine and Treatment Evaluation Units (VTEUs)
    
    

• General Questions and Answers on Thimerosal (a preservative) and H1N1
  (Source: Centers for Disease Control and Prevention)
  
  

• CDC 2009 H1N1 Vaccination Campaign Planning Checklist
  (Source: Centers for Disease Control and Prevention)
  
  
• Vaccine Distribution Q&A
  (Source: Centers for Disease Control and Prevention)
  
  
• CDC 2009 H1N1 Vaccination Campaign Planning Checklist
  (Source: Centers for Disease Control and Prevention)
  
  
• Vaccine Adverse Event Reporting System (VAERS) Healthcare Provider Letter and Reporting Form
  
  
• MMWR: Update on Influenza A (H1N1) 2009 Monovalent Vaccines
  (Source: Centers for Disease Control and Prevention)
  • Morbidity and Mortality Weekly Report (MMWR) October 9, 2009 / 58(39):1100-1101

_______________________________________________Back to top

Antivirals

• Questions & Answers: Antiviral Drugs, 2009-2010 Flu Season
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers for Pregnant Women: Use of Antivirals to Treat and Prevent Flu
  (Source: Centers for Disease Control and Prevention)
  
  
• Quick Facts for Clinicians on Antiviral Treatments for 2009 H1N1
  (Source: Centers for Disease Control and Prevention)
  
  
• Pediatric Supplement: Recommendations for use of antiviral medications for 2009 H1N1 influenza in children and adolescents
  (Source: Centers for Disease Control and Prevention)
  
  
• Opening and Mixing Tamiflu Capsules with Liquids if Child Cannot Swallow Capsules
  (Source: Centers for Disease Control and Prevention)
  
  
• Authorization to Use Expired Tamiflu for Oral Suspension
  (Source: Food & Drug Administration)
  
  
• 2009 H1N1 and Seasonal Flu: What You Should Know About Flu Antiviral Drugs
  (Source: Centers for Disease Control and Prevention)
  
  
• Antiviral Recommendations
  (Source: Centers for Disease Control and Prevention)
  
  
• Updated Pediatric Antiviral Dosing Syringe and Compounding Information
  (Source: Centers for Disease Control and Prevention)
  
  
• Antiviral Safety Information Web Page
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Provider Guidance for Specific Medical Conditions

• Updated Interim Recommendations: Special Considerations for Clinicians Regarding 2009 H1N1 Influenza in Severely Immunosuppressed Patients
  (Source: Centers for Disease Control and Prevention)
  
  
• Home Care Guidance: Physician Directions to Patient/Parent
  (Source: Centers for Disease Control and Prevention)
  
  
• Patients With Cardiovascular Disease
  (Source: Centers for Disease Control and Prevention)
  
  
• 2009 H1N1 Flu and Seasonal Flu Information for Rheumatology Health Professionals
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

HIV/AIDS

• HIV-Infected Adults and Adolescents
  (Source: Centers for Disease Control and Prevention)
  
  
• Guidance on HIV-Infected Adults and Adolescents: Considerations for Clinicians Regarding H1N1 Virus
  (Source: Centers for Disease Control and Prevention)
  
  
• Guidance on Antiviral Recommendations for Patients with H1N1 Virus Infection and Their Close Contacts
  (Includes antiviral treatment guidelines for children)(Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Facilities
General

• OSHA Influenza Preparedness and Response Guidance for Healthcare Workers and Healthcare Employers
  (Source: Occupational Safety and Health Administration)
  
  
• Infection Control Guidance on 2009 H1N1 Influenza for Personnel at Blood and Plasma Collection Facilities
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers about CDC's Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions and Answers Regarding Respiratory Protection For Preventing 2009 H1N1 Influenza Among Healthcare Personnel
  (Source: Centers for Disease Control and Prevention)
  
  
• Healthcare Workplaces Classified as Very High or High Exposure Risk for Pandemic Influenza,  What to do to protect workers. 
  (En Español)
  (Source: Occupational Safety & Health Administration)
  
  
• Health Insurer Pandemic Influenza Planning Checklist
  (Source: Flu.gov)
  
  
• Healthcare Personnel Initiative to Improve Influenza Vaccination and Toolkit
  (Source: U.S. Department of Health and Human Services)

_______________________________________________Back to top

Hospital

• Hospital Pandemic Influenza Planning Checklist
  (Source: Flu.gov)
  
  
• Pandemic Fact Sheet - EMTALA Requirements for Hospitals
  (Source: Centers for Medicare and Medicaid Services)

_______________________________________________Back to top

Home Health Care

• Home Health Care Services Checklist (En Español)
  (Source: Flu.gov)

_______________________________________________Back to top

Long-Term Care

• Long-Term Care and Other Residential Facilities Pandemic Influenza Planning Checklist
  (Source: Flu.gov)

_______________________________________________Back to top

Medical Offices and Outpatient Facilities

• Recommendations for Obstetric Healthcare Providers
  (Source: Centers for Disease Control and Prevention)
  
  
• 10 Actions Steps for Medical Offices and Outpatient Facilities
  (Source: Centers for Disease Control and Prevention)
  
  
• Medical Offices and Clinics Pandemic Influenza Planning Checklist
  (Source: Flu.gov)
  
  
• Infection Control in Outpatient Hemodialysis Centers
  (Source: Centers for Disease Control and Prevention)
  
  
• Considerations Regarding H1N1 Flu Virus in Obstetric Settings
  (Source: Centers for Disease Control and Prevention)
  
  
• Post-mortem Care and Safe Autopsy Procedures for H1N1 Influenza
  (Source: Centers for Disease Control and Prevention)
  
  
• Pediatrician Clinics Caring for Children
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Emergency Medical Services

• Managing Calls and Call Centers during a Large-Scale Influenza Outbreak: Implementation Tool
  (Source: Centers for Disease Control and Prevention)
  
  
• EMS and 9-1-1 Personnel:  Managing Confirmed or Suspected Infections
  (Source: Centers for Disease Control and Prevention)
  
  
• Emergency Medical Services and Non-Emergent (Medical) Transport Organizations Pandemic Influenza Planning Checklist 
  (Source: Flu.gov)

_______________________________________________Back to top

Laboratory Testing and Reporting

• Interim Guidance for Influenza Surveillance: Prioritizing RT-PCR Testing in Laboratories
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Recommendations for Clinical Use of Influenza Diagnostic Tests During the 2009-10 Influenza Season
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Guidance for State and Local Health Departments for Reporting Influenza-Associated Hospitalizations and Deaths for the 2009-2010 Season
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions & Answers for Clinicians on Interim Recommendations for Clinical Use of Influenza Diagnostic Testing During the 2009-2010 Influenza Season
  (Source: Centers for Disease Control and Prevention)
  
  
• Questions & Answers for the Public on Influenza Diagnostic Testing During the 2009-2010 Flu Season
  (Source: Centers for Disease Control and Prevention)

• Interim Guidance for the Detection of Novel Influenza A Virus Using Rapid Influenza Diagnostic Tests
  (Source: Centers for Disease Control and Prevention)
  
  
• Specimen Collection, Processing, and Testing for Suspected Infection
  (Source: Centers for Disease Control and Prevention)
  
  
• Submission of Tissue Specimens for Pathologic Evaluation
  (Source: Centers for Disease Control and Prevention)
  
  
• Protocol for Antiviral Susceptibility Testing by Pyrosequencing
  (Source: World Health Organization)
  
  
• Sequencing Primers and Protocol
  (Source: World Health Organization)
  
  
• Protocol of Realtime RTPCR for H1N1
  (Source:World Health Organization)
  
  
• DSAT Guidance on CDC Import Permits for Swine-Originated Flu
  (Source: Centers for Disease Control and Prevention)
  
  
• Interim Biosafety Guidance for All Individuals handling Clinical Specimens or Isolates containing 2009-H1N1 Influenza A Virus including Vaccine Strains  
  (Source: Centers for Disease Control and Prevention)

_______________________________________________Back to top

Finances

• CMS Free Care Rule for 2009 H1N1 Influenza Vaccination
  (Source:  Centers for Disease Control and Prevention)
  • Information on how the CMS Free Care Rule applies to H1N1 vaccine administration for Medicare and Medicaid beneficiaries
    
    
• Questions and Answers on 2009 H1N1 Vaccine Financing
  (Source: Centers for Disease Control and Prevention)
  
  
• H1N1 Vaccine Administration Billing Questions and Answer
  (Source: Centers for Disease Control and Prevention)
  • Questions and answers related to billing practices for H1N1 vaccine administration, including guidance about the circumstances under which providers may bill insurance or charge patients when federal funds for H1N1 vaccination are used.

_______________________________________________Back to top